Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Bloudek

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Managed Care & Specialty Pharmacy|February 28, 2020
The Effectiveness and Value of Siponimod for Secondary Progressive Multiple SclerosisPatricia G Synnott, Lisa M Bloudek, Ravi Sharaf, et al.
Headache|October 10, 2014
Real-world economic impact of onabotulinumtoxinA in patients with chronic migraineJohn F Rothrock, Lisa M Bloudek, Timothy T Houle, et al.
Health and Quality of Life Outcomes|August 2, 2014
Validation of the Headache Impact Test (HIT-6) in patients with chronic migraineRegina Rendas-Baum, Min Yang, Sepideh F Varon, et al.
Headache|June 11, 2014
Treatment persistence and switching in triptan users: a systematic literature reviewAndrew J Messali, Mo Yang, Patrick Gillard, et al.
Journal of Managed Care & Specialty Pharmacy|August 30, 2024
Development of stakeholder-informed recommendations for inclusion of family spillover effects in health technology assessmentDavid J Campbell, Rajshree Pandey, Lisa M Bloudek, et al.
Journal of Medical Economics|May 8, 2013
The cost-effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UKAnthony J Batty, Ryan N Hansen, Lisa M Bloudek, et al.
Headache|March 6, 2013
Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II)Andrew M Blumenfeld, Lisa M Bloudek, Werner J Becker, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 2, 2013
Headache-related health resource utilisation in chronic and episodic migraine across six countriesJoanna C Sanderson, Emily B Devine, Richard B Lipton, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Managed Care & Specialty Pharmacy|February 28, 2020
The Effectiveness and Value of Siponimod for Secondary Progressive Multiple SclerosisPatricia G Synnott, Lisa M Bloudek, Ravi Sharaf, et al.
Headache|October 10, 2014
Real-world economic impact of onabotulinumtoxinA in patients with chronic migraineJohn F Rothrock, Lisa M Bloudek, Timothy T Houle, et al.
Health and Quality of Life Outcomes|August 2, 2014
Validation of the Headache Impact Test (HIT-6) in patients with chronic migraineRegina Rendas-Baum, Min Yang, Sepideh F Varon, et al.
Headache|June 11, 2014
Treatment persistence and switching in triptan users: a systematic literature reviewAndrew J Messali, Mo Yang, Patrick Gillard, et al.
Journal of Managed Care & Specialty Pharmacy|August 30, 2024
Development of stakeholder-informed recommendations for inclusion of family spillover effects in health technology assessmentDavid J Campbell, Rajshree Pandey, Lisa M Bloudek, et al.
Journal of Medical Economics|May 8, 2013
The cost-effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UKAnthony J Batty, Ryan N Hansen, Lisa M Bloudek, et al.
Headache|March 6, 2013
Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II)Andrew M Blumenfeld, Lisa M Bloudek, Werner J Becker, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 2, 2013
Headache-related health resource utilisation in chronic and episodic migraine across six countriesJoanna C Sanderson, Emily B Devine, Richard B Lipton, et al.
Pageof 2